procedures. Further, the representative from the U.S. Arms Control and 
Disarmament Agency reported that the State Department considers the Bio- 
logical Weapons Convention as prohibiting development, production, or 
stockpiling of recombinant DNA molecules for purposes of biological war- 
fare. It was agreed, however, that the Committee, prior to concluding its 
business, should inquire into the activities in other countries relative to 
the use of recombinant DNA techniques and should make recommendations to 
the Secretary of HEW regarding Federal measures to promote international 
control. Recombinant DNA research has aroused widespread international 
debate, and the actions in other countries deserve careful attention when 
U.S. policy is being developed for legislation and regulation. (See 
Appendix III.) 
Accordingly, a Subcommittee on International Issues of the Inter- 
agency Committee on Recombinant DNA Research was created for the purpose 
of preparing an analysis of international activities to date and recom- 
mending means for achieving common safety standards wherever the use of 
recombinant DNA techniques takes place. The work of the Subcommittee 
and its recommendations are the basis for this Committee report. (See 
Appendix II for membership of the Subcommittee.) 
II . Subcommittee Review of International Recombinant DNA Activities 
Two meetings of the Subcommittee on International Issues were held to 
review recombinant DNA research activities outside the United States. To 
assist in this review, NIH staff prepared a survey of all recombinant DNA 
activities occurring internationally. The State Department subsequently 
2 
[ 386 ] 
